Related Experiment Videos
High-dose chemotherapy for chronic lymphocytic leukemia: eligibility, timing, and benefit?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.
Bone marrow transplantation·2016
New Agents and Strategies in CLL Treatment.
Leukemia & lymphoma·2016
Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
CAR-Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune-Mediated Inflammation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 - GRACIE trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Aplastic anemia developed after treatment with durvalumab].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Development of memory-like CAR-NK cells with durable antitumor activity].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Curcumin Suppresses Growth of Recurrent Colorectal Adenoma After Endoscopic Resection: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
The American journal of gastroenterology·2026